Navigation Links
Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
Date:11/7/2007

8 8

Additional paid in capital 40,819 38,947

Accumulated other comprehensive

income 115 106

Accumulated deficit (8,758) (11,206)

Total stockholders' equity 32,251 27,918

Total liabilities and stockholders'

equity $67,725 $62,907

SEGMENT INFORMATION

The Company operates in two businesses: Healthcare Services and Medical Products. The Company evaluates performance and allocates resources based on profit or loss from operations before income taxes, not including foreign exchange gains or losses. The following segment information has been provided per Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information:"

Healthcare Medical

Services Products Total

As of September 30, 2007:

Assets $38,174,000 $29,551,000 $67,725,000

For the three months ended

September 30, 2007:

Sales and service revenue $15,102,000 $17,550,000 $32,652,000

Gross Profit n/a* 4,634,000 n/a

Gross Profit % n/a* 26% n/a

Income from continuing operations

before foreign exchange $2,040,000 $304,000 $2,344,000

Foreign exchange gain 271,000

Income from continuing operations $2,615,000

Other (expense), net (134,000)

Income from continuing operations

before income taxes
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
2. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
5. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leadin... today announced the expansion of its services to ... Dr. Doug Macmillan. , ... pleased to announce that Dr. Doug Macmillan, an e... an additional advanced training seminar. RTDenta...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceu...panywillhosttwoinvestoreventsinDecember: ,, A...00a.m.ET ,, Principalinvestigatorswilldiscuss...nd/orrefractorymultiplemyeloma,asfeaturedatthe51st...positioninNewOrleans,LA.Theteleconferencewillbegin...
(Date:11/25/2009)...v.25/PRNewswire-USNewswire/--TheBlackAIDSInstitute...cutiveleadershipfor2010. ,, ThenewBoardMembersa...licpolicy,law,finance,governmenthealthprograms,edi...esfromawiderangeofpersonalbackgroundsincludingboth...IVthemselves,andrepresentingmultipleagegroups. ,...
(Date:11/25/2009)...overy that grew out of a collaboration between UCL... hope to the nearly 10 million Americans who suffe...nown as hardening of the arteries, peripheral arte...lem in which narrowed arteries reduce blood flow t...g for vascular disease, heart attack and stroke, a...
(Date:11/25/2009)...s could lead mothers to overlook needed care, stud...y News) -- A mother,s depression can worsen her ch...eir six-month study of 262 black mothers and their...re depressive symptoms had more frequent asthma sy...ssive symptoms had less frequent asthma symptoms. ...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
...co, Inc. is,pleased to announce the introduction o...rapid point of care system utilizes a chemilumines...separation method that allows,this system to repor...ole blood sample., The PATHFAST system can handle...
..., Inc.,(the "Company") (Nasdaq: AFAM ) announced ...public offering price of $17.75 per share. In conn...as been granted an option to,purchase up to 337,50...fering, after underwriting discounts,and estimated...
...heterogeneous group and may not always be associat...he study of 145 triple negative breast cancers (i....gesterone receptor-negative and HER2-negative) in ...of the study. , Triple negative breast cancer i...
...l can detect prostate cancer and provide undistort...te tumor localization, according to a recent study...ersity in Columbus, OH. , The 3T MRI datasets we... an endorectal coil leads to deformation of the pr...
...confirming large bowel obstruction and identifying... recent study conducted by researchers at the Univ...There is very little published evidence regarding ...n clinical problem and plain films have been shown...
...h 3T MR-guided focused ultrasound (MRgFUS) is safe...t study conducted by researchers at Weill Cornell ...25% of women in the United States have clinically ...n developed in radiology, includingnon-invasive MR...
Other Medicine News:Health News:Almost Family Announces Pricing of 2,250,000 Common Shares 2Health News:CT useful and effective when diagnosing patients with large bowel obstruction 2
(Date:11/25/2009)...A,Calif.,Nov.25/PRNewswire/--AMPACFineChemicalsLLC...aq: APFC )announcedtodaythatitreceivedtheEnvironme...lStatewideEnvironmentalSummit,sponsoredbytheCalifo...eIndustrialEnvironmentalAssociation(IEA)andtheChem...o.Thisisthemostprestigiousawardavailablefromallthr...
(Date:11/25/2009)...25/PRNewswire/--Reportlinker.comannouncesthatanewm..., MammographyEquipment-AGlobalMarketPerspective ...ography-Equipment---A-Global-Market-Perspective.ht...lizedaswellasdevelopingnationsisaprincipalfactorin...alatingawarenessaboutbreastcancerhasallowedwomento...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq: N...uctsforminimallydisruptivesurgicaltreatmentsforthe...nMonday,November30,2009,at5:30p.m.ET/2:30p.m.PT.Th...eimbursementfortheCompany,sproductsandwillincludec...swersession.Thedial-innumbersare1-877-407-4018ford...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 1KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 2KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 3KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 4KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 5KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 6Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 1Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 2Alzheimers Soars Global Focus Needed 3A Study 57748 1Alzheimers Soars Global Focus Needed 3A Study 57748 2Alzheimers Soars Global Focus Needed 3A Study 57748 3
... Inc. today,announced the completion of 6 month fo.... The results show a 78% reduction in Oswestry Dis...n Visual Analog Scores (VAS) for,symptomatic leg p...ons,added, "We are very pleased with these early r...icant pain relief but the safety of an anatomic an...
...,XTENT, Inc. (Nasdaq: XTNT ) today announced that... the CUSTOM I, II and III clinical trials next,wee...) twentieth annual,Transcatheter Cardiovascular Th...STOM clinical trials are prospective studies desig...Custom NX(R) drug eluting stent (DES) system,in tr...
Other Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2
Lorenz 2.0 mm Flexible Titanium
Craniofix Titanium Clamp
...e Cfix cable fixation system is a flexible titaniu...crimping and address the surgeon's need for intrao... provides the surgeon with the ability to retighte...tting without the need for additional cables. Quic...
Grafton DBM Crunch
Medicine Products: